Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 8/20 | 0.35 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
| ▸ | PRKACA | P17612 | 1/20 | 0.32 |
| ▸ | GRK5 | P34947 | 1/20 | 0.32 |
| ▸ | CDK8 | P49336 | 1/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.32 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.32 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30171415 | 0.66 | P2RX4 (0.35) | P2RX4 | |
| SCHEMBL2057181 | 0.66 | HPGD (0.37) | — | |
| SCHEMBL31031209 | 0.64 | GAA (0.33) | — | |
| SCHEMBL1343638 | 0.64 | P2RX4 (0.37) | P2RX4 | |
| SCHEMBL5655144 | 0.62 | ABCG2 (0.32) | ABCG2ITGB2ICAM1ITGAL | |
| SCHEMBL7286031 | 0.62 | DNMT1 (0.40) | — | |
| SCHEMBL15227014 | 0.62 | SMN1; SMN2 (0.50) | ITGB2ICAM1ITGAL | |
| SCHEMBL1962664 | 0.57 | P2RX1 (0.33) | P2RX4 | |
| SCHEMBL38662568 | 0.57 | PIM1 (0.49) | P2RX4 | |
| SCHEMBL6366067 | 0.57 | GAA (0.44) | P2RX4DAPK3RETPRKACAGRK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1652554-B1 | Composition comprising at least one carboycanine, process of treating keratinic fibres, kit and use of said composition | OREAL (FR) | 2010-01-13 | — | — | EP | claimed |
| US-7425221-B2 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2008-09-16 | — | — | US | claimed |
| US-20060195990-A1 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2006-09-07 | — | — | US | claimed |
| EP-1652554-A1 | Composition comprising at least one carboycanine, process of treating keratinic fibres, kit and use of said composition | L'OREAL (FR) | 2006-05-03 | — | — | EP | claimed |
| WO-2006030127-A1 | COMPOSITION COMPRISING AT LEAST ONE SUBSTITUTED CARBOCYANINE DERIVATIVE, KERATIN FIBRE TREATMENT METHOD USING SAME, ASSOCIATED DEVICE AND USE THEREOF | L'OREAL (FR) | 2006-03-23 | — | — | WO | claimed |
| EP-1652554-B1 | Composition comprising at least one carboycanine, process of treating keratinic fibres, kit and use of said composition | OREAL (FR) | 2010-01-13 | — | — | EP | disclosed |
| US-7425221-B2 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2008-09-16 | — | — | US | disclosed |
| US-20060195990-A1 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2006-09-07 | — | — | US | disclosed |
| WO-2006030127-A1 | COMPOSITION COMPRISING AT LEAST ONE SUBSTITUTED CARBOCYANINE DERIVATIVE, KERATIN FIBRE TREATMENT METHOD USING SAME, ASSOCIATED DEVICE AND USE THEREOF | L'OREAL (FR) | 2006-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060195990-A1 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | KRT18, KLK5, IK | P2RX4 4188/4885DAPK3 1745/4885RET 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.